A Systematic Review of Factor XI/XIa Inhibitors Versus Direct Oral Anticoagulants in Patients with Atrial Fibrillation. [PDF]
Xue Z, Liao S, Fan H, Shen Y, Nie Z.
europepmc +1 more source
Reducing Plasma Factor XI Concentration With siRNA Technology. [PDF]
Gailani D.
europepmc +1 more source
Safety of factor XI inhibitors compared to factor X inhibitors in atrial fibrillation: a systematic review and meta-analysis. [PDF]
Markides RIL +4 more
europepmc +1 more source
Toward an age of CRISPR delivery with non-viral biologics. [PDF]
Tompkins J, Ray RM, Scott TA.
europepmc +1 more source
Abelacimab for Acute Pulmonary Embolism: Translating Dual FXI/XIa Inhibition from Mechanism to Clinical Prospects. [PDF]
Luo M, Wu J.
europepmc +1 more source
A Year in Review: Atrial Fibrillation 2025. [PDF]
Taranto LM, Karnik AA, Doshi RN.
europepmc +1 more source
Role of toric intraocular lenses in the correction of keratoconic eyes with cataract. [PDF]
Francis SM +3 more
europepmc +1 more source
Comparative Metabolomic Responses of Three Rhododendron Cultivars to the Azalea Lace Bug (Stephanitis pyrioides). [PDF]
He B +7 more
europepmc +1 more source
Factor XI and Cancer: Physiopathological Linkage and Clinical Perspectives. [PDF]
Mauriello A +5 more
europepmc +1 more source

